Qelbree (viloxazine — non-stimulant option)
Qelbree (viloxazine) is a non-stimulant medication specifically approved for the treatment of ADHD in both children (ages 6–17) and adults. As a Selective Norepinephrine Reuptake Inhibitor (SNRI), it works by increasing the levels of norepinephrine in the brain, which helps to improve focus, attention, and impulse control. Unlike traditional stimulants, Qelbree is not a controlled substance, meaning it has no known potential for abuse or dependence and provides an alternative for patients who do not tolerate stimulants well.
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Qelbree(viloxazine extended-release capsules)
Is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.
What Are Side Effects of Qelbree?
Side effects of Qelbree include:
- drowsiness,
- decreased appetite,
- fatigue,
- nausea,
- vomiting,
- insomnia,
- irritability,
- headache,
- upper respiratory tract infection,
- abdominal pain, and
- fever
Dosage for Qelbree
The recommended starting dosage of Qelbree for pediatric patients 6 to 11 years of age is 100 mg once daily. The dose may be adjusted in increments of 100 mg weekly to the maximum recommended dosage of 400 mg once daily.
The recommended starting dosage of Qelbree for pediatric patients 12 to 17 years of age is 200 mg once daily. The dose may be adjusted after 1 week, by an increment of 200 mg, to the maximum recommended dosage of 400 mg once daily.
Qelbree During Pregnancy and Breastfeeding
Tell your doctor if you are pregnant or plan to become pregnant before using Qelbree; it may harm the mother. There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed Qelbree during pregnancy. It is unknown if Qelbree passes into breast milk. Consult your doctor before breastfeeding.
Additional Information
Our Qelbree (viloxazine extended-release capsules), for Oral Use Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Be the first to review “Qelbree (viloxazine — non-stimulant option)”
Related products
- Original price was: $319.$312.62Current price is: $312.62.
Quillivant XR (methylphenidate oral suspension)
Original price was: $280.$240Current price is: $240.
- Original price was: $12.90.$9.99Current price is: $9.99.
Reviews
There are no reviews yet.